MEXIDOL® Sequential Therapy of Patients With Primary Open-angle Glaucoma (POAG)

Summary

Hypothesis: The use of neurocytoprotectors helps restore the functional activity of mitochondria, improve the nervous activity of the retina and optic nerve, and stabilize the glaucomatous process.

Timeline

Start

2023-09-15

Primary completion

2023-11-29

Completion

2024-02-02

Drugs

Indications